Home Dermatology September 2000
September 2000
$2.79
Articles in this Issue:
- US FDA Advisory Committee Meetings Held to Discuss Isotretinoin, Safety Issues and a New Accutane Formulation
- Perspectives on Isotretinoin and the Canadian Consensus Guidelines on Treatment of Acne
- Update on Drugs and Drug News: Number 2, 2000
